Short diagnosis to treatment interval in relapsed or refractory large B-cell lymphoma treated with epcoritamab
Journal of Clinical and Experimental Hematopathology · 2026
DOI: 10.3960/jslrt.26056 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical and Experimental Hematopathology, 2026. Verfasst von Kazuhito Suzuki und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University School of Medicine, Tokyo, Japan.
- Division of Clinical Oncology/Hematology, Department of internal medicine, The Jikei University Kashiwa Hospital, Kashiwa, Chiba, Japan.
Zitieren
APA
Suzuki, K., Uryu, H., Gunji, T., Hirano, K., Nakamura, T., Ishii, K., Fukushima, R., Yokoyama, H., Ishii, H., Hosoba, R., Hattori, D., Momoki, M., Mochizuki, Y., Nagao, R., Katori, M., Nishiwaki, K., & Yano, S. (2026). Short diagnosis to treatment interval in relapsed or refractory large B-cell lymphoma treated with epcoritamab. Journal of Clinical and Experimental Hematopathology. https://doi.org/10.3960/jslrt.26056
Vancouver
Suzuki K, Uryu H, Gunji T, Hirano K, Nakamura T, Ishii K, et al. Short diagnosis to treatment interval in relapsed or refractory large B-cell lymphoma treated with epcoritamab. Journal of Clinical and Experimental Hematopathology. 2026. doi:10.3960/jslrt.26056
BibTeX
@article{Suzuki2026,
author = {Suzuki, Kazuhito and Uryu, Hideki and Gunji, Tadahiro and Hirano, Kei and Nakamura, Takashi and Ishii, Keita and Fukushima, Ryoko and Yokoyama, Hiroki and Ishii, Hiroto and Hosoba, Rika and Hattori, Daiki and Momoki, Mamiko and Mochizuki, Yasutaka and Nagao, Riku and Katori, Mitsuji and Nishiwaki, Kaichi and Yano, Shingo},
title = {Short diagnosis to treatment interval in relapsed or refractory large B-cell lymphoma treated with epcoritamab},
journal = {Journal of Clinical and Experimental Hematopathology},
year = {2026},
doi = {10.3960/jslrt.26056}
}
EUVIMED